Journal article · 2026
Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs
Journal of Medicinal Chemistry · Published 11 November 2026 · DOI 10.1021/acs.jmedchem.6c02050
In brief
“Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs” is a 2026 journal article by William T. Windsor, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 70
- Authors
- 1
Abstract
Breakthrough hit-finding platforms rarely become routine after the first novel proof-of-concept and realistically take 20−30 years to develop fully. Across FBDD, DEL, Aptamer, and PROTAC drug discovery technologies, the persistent rate-limiting issue in platform development is not the founding concept alone (e.g., chemistry) rather, it is often more likely due to organizations underestimating the time… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Windsor, W. T. (2026). Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02050
MLA 9
Windsor, William T. “Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02050.
Chicago
Windsor, William T. 2026. “Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02050.
Harvard
Windsor, W. T. (2026) ‘Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02050.
IEEE
W. T. Windsor, “Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02050.
BibTeX
@article{windsor2026breakthrough,
title = {{Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs}},
author = {Windsor, William T.},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02050},
url = {https://doi.org/10.1021/acs.jmedchem.6c02050}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- fragment-based drug discovery
- DNA-encoded libraries
- aptamers
- PROTACs
- hit finding
- return on investment
- lessons learned
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Windsor, W. T. (2026). Why Breakthrough Drug Discovery Platforms Need Decades to Mature: Lessons from FBDD, DEL, Aptamers, and PROTACs. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02050
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
William T. Windsor.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c02050, permanently at https://doi.org/10.1021/acs.jmedchem.6c02050. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.